GI Pathogens Plus Profile

The GI Pathogen Plus Profile (GPP) is a multiplexed nucleic acid test that is designed to not only be a qualitative identification of various organisms and toxins often seen in patients with GI issues and illnesses, but also a quantitative value that may be useful in following the infection over time. Furthermore, DRG is the only laboratory on the market that performs quantitative assessment of a patient’s susceptibility pattern to commonly prescribed antibiotics,  to better guide the judicious and appropriate use of antimicrobials. This panel includes patient specific genetic Antibiotic Resistance. DRG also performs quantitation of several GI health markers to provide the health care practitioner valuable information in confidently identifying issues such as gluten sensitivity, inflammation associated with conditions such as inflammatory bowel disease, and helps track the activity and severity of these crucial and often misunderstood diseases.

Pediatric Plus Profile

The Pediatric Plus Profile (PPP) is a multiplexed nucleic acid test that is designed to provide not only a qualitative identification of various organisms and toxins often see in pediatric patients with GI issues and illnesses, but also a quantitative value that may be useful in following the identified infection over time. Furthermore, DRG is the only laboratory on the market that performs quantitative assessment of a patient’s susceptibility pattern to commonly prescribed antibiotics, to better guide the judicious and appropriate use of antimicrobials. DRG also performs quantitation of several GI health markers to provide the health care practitioner valuable information in confidently identifying issues such as gluten sensitivity, inflammation associated with conditions such as inflammatory bowel disease, and helps track the activity and severity of these crucial and often misunderstood diseases. It is important to note that the markers for H. pylori are not identified in this assay, as this infection is often miscategorized in younger patients. As with our larger panel, it includes patient specific genetic Antibiotic Resistance.

H. pylori Eradication – Stool Profile

The Helicobacter pylori eradication (HPE) assay is performed on stool and detects multiple markers that are useful in the detection of H. pylori in the stool. One critical difference is that the HPE assay also evaluates the HP stool antigen value, a crucial value that helps the clinician determine if an H. pylori infection is not only present, but also active, and should be treated. As with our larger panel, it includes patient specific genetic Antibiotic Resistance.

H. pylori Biopsy Profile

The Helicobacter pylori assay panel (HPP) is designed to investigate for multiple H. pylori markers by molecular methods. As with our larger panel, it includes patient specific genetic Antibiotic Resistance.
Read Offline:
Share This